{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:00:54Z","timestamp":1770447654752,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:00:00Z","timestamp":1471046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:00:00Z","timestamp":1471046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24DK082792A"],"award-info":[{"award-number":["K24DK082792A"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s40272-016-0189-x","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T01:06:31Z","timestamp":1471050391000},"page":"387-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Utility of Octreotide in Advancing Enteral Feeds in Children with Chronic Intestinal Pseudo-Obstruction"],"prefix":"10.1007","volume":"18","author":[{"given":"Lusine","family":"Ambartsumyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Nurko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7128-6048","authenticated-orcid":false,"given":"Leonel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,13]]},"reference":[{"issue":"5","key":"189_CR1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/00005176-199811000-00002","volume":"27","author":"C Di Lorenzo","year":"1998","unstructured":"Di Lorenzo C, Lucanto C, Flores AF, Idries S, Hyman PE. Effect of octreotide on gastrointestinal motility in children with functional gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 1998;27(5):508\u201312 (Epub 1998\/11\/20).","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"189_CR2","unstructured":"Lecomte T, Cavicchi M, Delchier JC. Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin. Gastroenterol Clin Biol. 2000;24(3):361\u20133 (pii: MDOI-GCB-03-2000-24-3-0399-8320-101019-ART16. Epub 2000\/05\/11)."},{"key":"189_CR3","doi-asserted-by":"publisher","unstructured":"Leonardi G, de Bortoli N, Bellini M, Mumolo MG, Costa F, Ricchiuti A, et al. Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding. World J Gastrointest Pharmacol Ther. 2010;1(6):135\u20136. doi:\n                    10.4292\/wjgpt.v1.i6.135\n                    \n                   \n                           (Epub 2011\/05\/18).","DOI":"10.4292\/wjgpt.v1.i6.135"},{"issue":"5","key":"189_CR4","first-page":"768","volume":"39","author":"M Ishikawa","year":"1999","unstructured":"Ishikawa M, Okada J, Kondo H. Five cases of systemic sclerosis with associated with intestinal pseudo-obstruction. Ryumachi. 1999;39(5):768\u201373 (Epub 1999\/12\/30).","journal-title":"Ryumachi."},{"key":"189_CR5","unstructured":"Lanting PJ, Kruijsen MW, Rasher JJ, van den Hoogen FH, Boerbooms AM, van de Putte LB. Severe intestinal pseudoobstruction in a patient with systemic sclerosis. Successful treatment with octreotide. J Rheumatol. 1993;20(12):2175 (Epub 1993\/12\/01)."},{"issue":"7","key":"189_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2169\/internalmedicine.32.607","volume":"32","author":"T Kobayashi","year":"1993","unstructured":"Kobayashi T, Kobayashi M, Naka M, Nakajima K, Momose A, Toi M. Response to octreotide of intestinal pseudoobstruction and pneumatosis cystoides intestinalis associated with progressive systemic sclerosis. Intern Med. 1993;32(7):607\u20139 (Epub 1993\/07\/01).","journal-title":"Intern Med"},{"key":"189_CR7","doi-asserted-by":"crossref","unstructured":"Suzuki C, Ohara M, Yamamoto M, Naishiro Y, Yamamoto H, Takahashi H, et al. A case of scleroderma-polymyositis overlap syndrome in which octreotide exacerbated abdominal symptoms. Nihon Rinsho Meneki Gakkai Kaishi. 2005;28(1):56\u201361 (pii:JST.JSTAGE\/jsci\/28. Epub 2005\/03\/04).","DOI":"10.2177\/jsci.28.56"},{"key":"189_CR8","doi-asserted-by":"publisher","unstructured":"Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325(21):1461\u20137. doi:\n                    10.1056\/NEJM199111213252102\n                    \n                   \n                           (Epub 1991\/11\/21).","DOI":"10.1056\/NEJM199111213252102"},{"issue":"9","key":"189_CR9","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1007\/BF02208652","volume":"40","author":"GN Verne","year":"1995","unstructured":"Verne GN, Eaker EY, Hardy E, Sninsky CA. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci. 1995;40(9):1892\u2013901 (Epub 1995\/09\/01).","journal-title":"Dig Dis Sci"},{"key":"189_CR10","doi-asserted-by":"publisher","unstructured":"Perlemuter G, Cacoub P, Chaussade S, Wechsler B, Couturier D, Piette JC. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases. Arthritis Rheum. 1999;42(7):1545\u20139. doi:\n                    10.1002\/1529-0131(199907)42:7<1545::AID-ANR30>3.0.CO;2-T\n                    \n                   \n                           (Epub 1999\/07\/14).","DOI":"10.1002\/1529-0131(199907)42:7%3c1545::AID-ANR30%3e3.0.CO;2-T"},{"key":"189_CR11","doi-asserted-by":"publisher","unstructured":"Nikou GC, Toumpanakis C, Katsiari C, Charalambopoulos D, Sfikakis PP. Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients. J Clin Rheumatol. 2007;13(3):119\u201323. doi:\n                    10.1097\/RHU.0b013e3180645d2a\n                    \n                   \n                           (Epub 2007\/06\/07).","DOI":"10.1097\/RHU.0b013e3180645d2a"},{"issue":"11","key":"189_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4103\/0019-5359.27974","volume":"60","author":"S Sharma","year":"2006","unstructured":"Sharma S, Ghoshal UC, Bhat G, Choudhuri G. Gastric adenocarcinoma presenting with intestinal pseudoobstruction, successfully treated with octreotide. Indian J Med Sci. 2006;60(11):467\u201370 (Epub 2006\/11\/09).","journal-title":"Indian J Med Sci"},{"key":"189_CR13","doi-asserted-by":"publisher","unstructured":"Sorhaug S, Steinshamn SL, Waldum HL. Octreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLC. Lung Cancer. 2005;48(1):137\u201340. doi:\n                    10.1016\/j.lungcan.2004.09.008\n                    \n                   \n                           (Epub 2005\/03\/22).","DOI":"10.1016\/j.lungcan.2004.09.008"},{"issue":"2","key":"189_CR14","first-page":"93","volume":"16","author":"B Dalgic","year":"2005","unstructured":"Dalgic B, Sari S, Dogan I, Unal S. Chronic intestinal pseudoobstruction: report of four pediatric patients. Turk J Gastroenterol. 2005;16(2):93\u20137 (Epub 2005\/10\/28).","journal-title":"Turk J Gastroenterol."},{"issue":"1","key":"189_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00005176-199701000-00021","volume":"24","author":"CD Rudolph","year":"1997","unstructured":"Rudolph CD, Hyman PE, Altschuler SM, Christensen J, Colletti RB, Cucchiara S, et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr. 1997;24(1):102\u201312 (Epub 1997\/01\/01).","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"189_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S0022-3476(05)80229-X","volume":"120","author":"C Di Lorenzo","year":"1992","unstructured":"Di Lorenzo C, Flores AF, Reddy SN, Hyman PE. Use of colonic manometry to differentiate causes of intractable constipation in children. J Pediatr. 1992;120(5):690\u20135.","journal-title":"J Pediatr"},{"issue":"1","key":"189_CR17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0095-5108(18)30308-7","volume":"22","author":"CL Berseth","year":"1995","unstructured":"Berseth CL. Minimal enteral feedings. Clin Perinatol. 1995;22(1):195\u2013205 (Epub 1995\/03\/01).","journal-title":"Clin Perinatol"},{"issue":"9","key":"189_CR18","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/jn\/132.9.2717","volume":"132","author":"L Owens","year":"2002","unstructured":"Owens L, Burrin DG, Berseth CL. Minimal enteral feeding induces maturation of intestinal motor function but not mucosal growth in neonatal dogs. J Nutr. 2002;132(9):2717\u201322 (Epub 2002\/09\/11).","journal-title":"J Nutr"},{"key":"189_CR19","doi-asserted-by":"publisher","unstructured":"Shou J, Lappin J, Minnard EA, Daly JM. Total parenteral nutrition, bacterial translocation, and host immune function. Am J Surg. 1994;167(1):145\u201350. doi:\n                    10.1016\/0002-9610(94)90065-5\n                    \n                   \n                           (Epub 1994\/01\/01).","DOI":"10.1016\/0002-9610(94)90065-5"},{"key":"189_CR20","doi-asserted-by":"crossref","unstructured":"Okada Y, Klein N, van Saene HK, Pierro A. Small volumes of enteral feedings normalise immune function in infants receiving parenteral nutrition. J Pediatr Surg. 1998;33(1):16\u20139 (pii:S0022-3468(98)90352-9. Epub 1998\/02\/24).","DOI":"10.1016\/S0022-3468(98)90352-9"},{"issue":"6","key":"189_CR21","first-page":"446","volume":"9","author":"V Descamps","year":"1999","unstructured":"Descamps V, Duval X, Crickx B, Bouscarat F, Coffin B, Belaich S. Global improvement of systemic scleroderma under long-term administration of octreotide. Eur J Dermatol. 1999;9(6):446\u20138 (Epub 1999\/09\/24).","journal-title":"Eur J Dermatol."},{"issue":"11","key":"189_CR22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00042737-200511000-00009","volume":"17","author":"K Sjolund","year":"2005","unstructured":"Sjolund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Akesson A. Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol. 2005;17(11):1205\u201312.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"189_CR23","first-page":"905","volume":"35","author":"C Folwaczny","year":"1997","unstructured":"Folwaczny C, Laritz M, Meurer M, Endres SP, Konig A, Schindlbeck N. Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma. Z Gastroenterol. 1997;35(10):905\u201312 (Epub 1998\/02\/12).","journal-title":"Z Gastroenterol"},{"issue":"10","key":"189_CR24","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1001\/archderm.131.10.1207","volume":"131","author":"M Pavlovic","year":"1995","unstructured":"Pavlovic M, Saiag P, Lotz JP, Marinho E, Clerici T, Izrael V. Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide. Arch Dermatol. 1995;131(10):1207\u20139 (Epub 1995\/10\/01).","journal-title":"Arch Dermatol"},{"key":"189_CR25","doi-asserted-by":"publisher","unstructured":"Yarze JC, Chase MP. Free intra-abdominal gas associated with octreotide use: intestinal perforation or benign pneumoperitoneum associated with underlying systemic sclerosis? Am J Gastroenterol. 2002;97(7):1844\u20135. doi:\n                    10.1111\/j.1572-0241.2002.05865.x\n                    \n                   \n                           (Epub 2002\/07\/24).","DOI":"10.1111\/j.1572-0241.2002.05865.x"},{"key":"189_CR26","doi-asserted-by":"publisher","unstructured":"Malcolm A, Ellard K. Intestinal perforation associated with octreotide therapy in scleroderma. Am J Gastroenterol. 2001;96(11):3206\u20138. doi:\n                    10.1111\/j.1572-0241.2001.05286.x\n                    \n                   \n                           (Epub 2001\/11\/28).","DOI":"10.1111\/j.1572-0241.2001.05286.x"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-016-0189-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0189-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:10:49Z","timestamp":1589670649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-016-0189-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,13]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["189"],"URL":"https:\/\/doi.org\/10.1007\/s40272-016-0189-x","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,13]]},"assertion":[{"value":"13 August 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was supported in part by NIH K24DK082792A (SN).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"LA: no disclosures, AF: no disclosures, SN: no disclosures, LR: no disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}